Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jeffrey Conn

Showing results (51-60 of 416) with videos related to

Pageof 42
Sort By:
Alcoholism, Clinical and Experimental Research|January 12, 2021
Increased Synaptic Strength and mGlu<sub>2/3</sub> Receptor Plasticity on Mouse Prefrontal Cortex Intratelencephalic Pyramidal Cells Following Intermittent Access to EthanolMax E Joffe, Danny G Winder, P Jeffrey Conn
Current Opinion in Drug Discovery & Development|September 3, 2010
Orthosteric- and allosteric-induced ligand-directed trafficking at GPCRsGregory J Digby, P Jeffrey Conn, Craig W Lindsley
Discovery Medicine|January 1, 2013
Emerging approaches for treatment of schizophrenia: modulation of cholinergic signalingDaniel J Foster, Carrie K Jones, P Jeffrey Conn
Journal of Neurochemistry|October 3, 2002
Differential regulation of metabotropic glutamate receptor 5-mediated phosphoinositide hydrolysis and extracellular signal-regulated kinase responses by protein kinase C in cultured astrocytesRichard D Peavy, Scott D Sorensen, P Jeffrey Conn
CNS & Neurological Disorders Drug Targets|August 26, 2009
Glutamate receptors as therapeutic targets for Parkinson's diseaseKari A Johnson, P Jeffrey Conn, Colleen M Niswender
Molecular Biosystems|June 29, 2010
Allosteric activators of muscarinic receptors as novel approaches for treatment of CNS disordersGregory J Digby, Jana K Shirey, P Jeffrey Conn
Behavioural Brain Research|March 1, 2021
Targeting muscarinic receptors to treat schizophreniaDaniel J Foster, Zoey K Bryant, P Jeffrey Conn
Current Topics in Medicinal Chemistry|September 24, 2005
New therapeutic frontiers for metabotropic glutamate receptorsColleen M Niswender, Carrie K Jones, P Jeffrey Conn
Discovery Medicine|December 4, 2012
Emerging approaches for treatment of schizophrenia: modulation of glutamatergic signalingMeredith J Noetzel, Carrie K Jones, P Jeffrey Conn
Trends in Pharmacological Sciences|December 9, 2008
Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophreniaP Jeffrey Conn, Craig W Lindsley, Carrie K Jones
Pageof 42

Showing results (51-60 of 416) with videos related to

Sort By:
Pageof 42
Alcoholism, Clinical and Experimental Research|January 12, 2021
Increased Synaptic Strength and mGlu<sub>2/3</sub> Receptor Plasticity on Mouse Prefrontal Cortex Intratelencephalic Pyramidal Cells Following Intermittent Access to EthanolMax E Joffe, Danny G Winder, P Jeffrey Conn
Current Opinion in Drug Discovery & Development|September 3, 2010
Orthosteric- and allosteric-induced ligand-directed trafficking at GPCRsGregory J Digby, P Jeffrey Conn, Craig W Lindsley
Discovery Medicine|January 1, 2013
Emerging approaches for treatment of schizophrenia: modulation of cholinergic signalingDaniel J Foster, Carrie K Jones, P Jeffrey Conn
Journal of Neurochemistry|October 3, 2002
Differential regulation of metabotropic glutamate receptor 5-mediated phosphoinositide hydrolysis and extracellular signal-regulated kinase responses by protein kinase C in cultured astrocytesRichard D Peavy, Scott D Sorensen, P Jeffrey Conn
CNS & Neurological Disorders Drug Targets|August 26, 2009
Glutamate receptors as therapeutic targets for Parkinson's diseaseKari A Johnson, P Jeffrey Conn, Colleen M Niswender
Molecular Biosystems|June 29, 2010
Allosteric activators of muscarinic receptors as novel approaches for treatment of CNS disordersGregory J Digby, Jana K Shirey, P Jeffrey Conn
Behavioural Brain Research|March 1, 2021
Targeting muscarinic receptors to treat schizophreniaDaniel J Foster, Zoey K Bryant, P Jeffrey Conn
Current Topics in Medicinal Chemistry|September 24, 2005
New therapeutic frontiers for metabotropic glutamate receptorsColleen M Niswender, Carrie K Jones, P Jeffrey Conn
Discovery Medicine|December 4, 2012
Emerging approaches for treatment of schizophrenia: modulation of glutamatergic signalingMeredith J Noetzel, Carrie K Jones, P Jeffrey Conn
Trends in Pharmacological Sciences|December 9, 2008
Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophreniaP Jeffrey Conn, Craig W Lindsley, Carrie K Jones
Pageof 42